Skip to main content
PMC home page
Heart logoLink to Heart
. 2000 Jul;84(1):37–40. doi: 10.1136/heart.84.1.37

Randomised double blind trial of oral versus intravenous flecainide for the cardioversion of acute atrial fibrillation

N Alp 1, J Bell 1, M Shahi 1
PMCID: PMC1729414  PMID: 10862585

Abstract

OBJECTIVE—To investigate whether an oral loading dose of flecainide is as safe and effective as intravenous flecainide for the cardioversion of acute atrial fibrillation.
DESIGN—Prospective, randomised, double blind, double placebo study.
SETTING—Cardiac care unit of a large district general hospital in the UK.
PATIENTS AND METHODS—79 patients presenting with symptomatic acute atrial fibrillation: patients were given either intravenous flecainide (n = 39) or a solution of oral flecainide (n = 40), with appropriate placebos. All patients were heparinised during the study.
PRIMARY OUTCOME MEASURES—Safety; mean time to cardioversion; proportion of patients restored to sinus rhythm at two hours and eight hours after treatment. Analysis was by intention to treat.
RESULTS—There were no differences in baseline characteristics between the oral and intravenous groups. Both forms of flecainide were well tolerated, with no adverse clinical events during the study. The mean time to cardioversion was 110 minutes in the oral group and 52 minutes in the intravenous group (p = 0.002). Two hours after treatment, 27 of the 40 patients in the oral group (68%) and 25 of the 39 in the intravenous group (64%) had reverted to sinus rhythm (p = 0.74). Eight hours after treatment, 30 patients in the oral group (75%) and 28 in the intravenous group (72%) had reverted to sinus rhythm (p = 0.76).
CONCLUSIONS—Intravenous flecainide restored sinus rhythm more rapidly than oral flecainide, but at two hours and eight hours after treatment there was no difference in the proportion of patients cardioverted by the two approaches. These results suggest a role for oral loading doses of flecainide in the treatment of acute or symptomatic paroxysmal atrial fibrillation.


Keywords: atrial fibrillation; flecainide

Full Text

The Full Text of this article is available as a PDF (120.1 KB).

Figure 1  .

Figure 1  

Open in a new tab

Trial profile.

Figure 2  .

Figure 2  

Open in a new tab

Cumulative cardioversion rates for oral and intravenous flecainide.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Capucci A., Boriani G., Botto G. L., Lenzi T., Rubino I., Falcone C., Trisolino G., Della Casa S., Binetti N., Cavazza M. Conversion of recent-onset atrial fibrillation by a single oral loading dose of propafenone or flecainide. Am J Cardiol. 1994 Sep 1;74(5):503–505. doi: 10.1016/0002-9149(94)90915-6. [DOI] [PubMed] [Google Scholar]
  2. Capucci A., Lenzi T., Boriani G., Trisolino G., Binetti N., Cavazza M., Fontana G., Magnani B. Effectiveness of loading oral flecainide for converting recent-onset atrial fibrillation to sinus rhythm in patients without organic heart disease or with only systemic hypertension. Am J Cardiol. 1992 Jul 1;70(1):69–72. doi: 10.1016/0002-9149(92)91392-h. [DOI] [PubMed] [Google Scholar]
  3. Crijns H. J., van Wijk L. M., van Gilst W. H., Kingma J. H., van Gelder I. C., Lie K. I. Acute conversion of atrial fibrillation to sinus rhythm: clinical efficacy of flecainide acetate. Comparison of two regimens. Eur Heart J. 1988 Jun;9(6):634–638. doi: 10.1093/oxfordjournals.eurheartj.a062553. [DOI] [PubMed] [Google Scholar]
  4. Donovan K. D., Power B. M., Hockings B. E., Dobb G. J., Lee K. Y. Intravenous flecainide versus amiodarone for recent-onset atrial fibrillation. Am J Cardiol. 1995 Apr 1;75(10):693–697. doi: 10.1016/s0002-9149(99)80655-9. [DOI] [PubMed] [Google Scholar]
  5. Hage K., Bühl K., Fischer C., Knebel N. G. Estimation of the absolute bioavailability of flecainide using stable isotope technique. Eur J Clin Pharmacol. 1995;48(1):51–55. doi: 10.1007/BF00202172. [DOI] [PubMed] [Google Scholar]
  6. Lie-A-Huen L., Proost J. H., Kingma J. H., Meijer D. K. Absorption kinetics of oral and rectal flecainide in healthy subjects. Eur J Clin Pharmacol. 1990;38(6):595–598. doi: 10.1007/BF00278588. [DOI] [PubMed] [Google Scholar]
  7. Madrid A. H., Moro C., Marín-Huerta E., Mestre J. L., Novo L., Costa A. Comparison of flecainide and procainamide in cardioversion of atrial fibrillation. Eur Heart J. 1993 Aug;14(8):1127–1131. doi: 10.1093/eurheartj/14.8.1127. [DOI] [PubMed] [Google Scholar]
  8. Suttorp M. J., Kingma J. H., Lie-A-Huen L., Mast E. G. Intravenous flecainide versus verapamil for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm. Am J Cardiol. 1989 Mar 15;63(11):693–696. doi: 10.1016/0002-9149(89)90253-1. [DOI] [PubMed] [Google Scholar]
  9. Van Gelder I. C., Crijns H. J., Van Gilst W. H., Verwer R., Lie K. I. Prediction of uneventful cardioversion and maintenance of sinus rhythm from direct-current electrical cardioversion of chronic atrial fibrillation and flutter. Am J Cardiol. 1991 Jul 1;68(1):41–46. doi: 10.1016/0002-9149(91)90707-r. [DOI] [PubMed] [Google Scholar]
  10. Wijffels M. C., Kirchhof C. J., Dorland R., Allessie M. A. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation. 1995 Oct 1;92(7):1954–1968. doi: 10.1161/01.cir.92.7.1954. [DOI] [PubMed] [Google Scholar]
  11. Yli-Mäyry S., Huikuri H. V., Airaksinen K. E., Ikäheimo M. J., Linnaluoto M. K., Takkunen J. T. Usefulness of a postoperative exercise test for predicting cardiac events after coronary artery bypass grafting. Am J Cardiol. 1992 Jul 1;70(1):56–59. doi: 10.1016/0002-9149(92)91389-l. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

[Correction to figure 2]
heart_84_1_37__index.html (1.5KB, html)

Articles from Heart are provided here courtesy of BMJ Publishing Group

RESOURCES